Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

6.59USD
16 Oct 2018
Change (% chg)

$0.44 (+7.15%)
Prev Close
$6.15
Open
$6.15
Day's High
$6.64
Day's Low
$6.15
Volume
13,434
Avg. Vol
9,940
52-wk High
$10.25
52-wk Low
$4.94

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $50.10
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -3.51 -- --
ROI: -4,400.15 0.73 14.32
ROE: -- 1.82 16.04

Earnings vs. Estimates